Sanofi Genzyme Revenue and Competitors
Estimated Revenue & Valuation
- Sanofi Genzyme's estimated annual revenue is currently $1.9B per year. 0
- Sanofi Genzyme's total funding is $639M.
Employee Data
- 00
Sanofi Genzyme's People
| Name | Title | Email/Phone |
|---|---|---|
1 | System owner C3P1 mAbs 2 | Reveal Email/Phone |
2 | Utility System Owner | Reveal Email/Phone |
3 | MSS System Owner Project Stella. | Reveal Email/Phone |
4 | VP, Global Head (GPH) Early Development, Neuroscience | Reveal Email/Phone |
5 | Head Rare Diseases UK | Reveal Email/Phone |
6 | VP, Head Global Medical, Immunology | Reveal Email/Phone |
7 | Head Manufacturing | Reveal Email/Phone |
8 | Head Sanofi Genzyme Europe | Reveal Email/Phone |
9 | Head Rare Diseases, North America | Reveal Email/Phone |
10 | Head, Technology Transfers and Life Cycle Program Management, Specialty Care IA | Reveal Email/Phone |
Sanofi Genzyme Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Sanofi Genzyme?
Genzyme General develops and markets therapeutic products and diagnostic products and services. Genzyme General has five therapeutic products on the market and a strong pipeline of products in development focused on the treatment of genetic disorders and other chronic debilitating diseases with well-defined patient populations. Genzyme General is a division of the biotechnology company Genzyme Corporation.
keywords:N/A
$639M
Total Funding
N/A
Number of Employees
$1.9B
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanofi Genzyme News
A startup that was spun out of Sanofi ADR in late 2019 is finally ready to share more about its work. Sionna Therapeutics, a cystic...
Sionna Therapeutics, a Sanofi Genzyme spinout, announced its launch with $111 million in Series B financing led by OrbiMed.
The life sciences giant Sanofi is now working from one of its two towers ... under the name Sanofi, subsuming offshoots like Sanofi Genzyme.
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $64.9M | 0 | N/A | $751.3M |
#2 | $12.9M | 0 | N/A | $163M |
#3 | $9.8M | 0 | N/A | $39M |
#4 | $4.8M | 0 | N/A | N/A |
#5 | $33.3M | 0 | N/A | $15M |